Mordecai Lab

Name

Mordecai Lab

Legal name

Mordecai Lab, Stanford University

Website

https://mordecailab.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Academic Research in Disease Ecology

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Modeling, Forecasting & Risk Assessment for Outbreaks (HLAJABAM)

akta.pro secondary industries

Vector-Borne Disease Surveillance & Control (HLAJABAG), One Health & Zoonotic Disease Partnerships (Human–Animal–Environment) (HLAJAOAJ), Vector Control & Veterinary Entomology Programs (HLAMAJAI)

Keywords

• Infectious disease research
• Disease ecology modeling
• Vector-borne disease research
• Mathematical epidemiology
• Climate-disease interactions

Headquarters

HQ city

Stanford

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Research Grants: Funded by competitive grants from government agencies and foundations including NSF Ecology and Evolution of Infectious Diseases Program, NIH NIGMS MIRA grant, Stanford Woods Institute for the Environment, and Moore Foundation.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Mordecai Lab conducts academic research on the ecology of infectious diseases, combining mathematical modeling with empirical laboratory and field data. The lab studies environmental drivers (climate, land use, species invasions) of vector-borne diseases such as malaria, dengue, chikungunya, and Zika, as well as pathogen impacts on plant communities and mosquito-parasite coevolutionary dynamics. Outputs include peer-reviewed publications, predictive models, and publicly available tools such as the COVID-19 Event Risk Assessment.

Product overview

Mordecai Lab is a university research laboratory at Stanford University, not a commercial product company. It does not offer products or services for sale. The lab conducts scientific research on the ecology of infectious disease, focusing on how climate, species interactions, and global change drive disease dynamics in humans and natural ecosystems. Research areas include environmental drivers of vector-borne disease, temperature effects on vector-transmitted diseases, pathogen impacts on plant communities, and eco-evolutionary dynamics of mosquito-parasite interactions. The lab produces academic publications, trains graduate students and postdocs, and provides educational blog content on career development in ecology.

Differentiator

Problem solved

Functional benefit

Products and services

• Disease Ecology Research Program
• COVID-19 Event Risk Assessment Tool
• EEID 2024 Conference Hosting

Quantifiable outcome

• Optimal temperature for malaria transmission identified at 25°C, 6°C lower than previous models predicted
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Stanford Woods Institute for the EnvironmentcoreStrategic or Co-development PartnerStanford Woods Institute Environmental Ventures Program funds research on climate and socioeconomic factors affecting dengue transmission in Kenya, Ecuador, and Costa Rica.
• Natural Capital ProjectcoreStrategic or Co-development PartnerCollaboration with Andy MacDonald, Lisa Mandle at Natural Capital Project to study impacts of deforestation on malaria in the Amazon, funded by Moore Foundation.
• Alameda and San Mateo County Mosquito Abatement DistrictsminorStrategic or Co-development PartnerCollaboration on western tree hole mosquito and ciliate parasite research, with Otto Seppälä, Jan Washburn, and Angie Nakano.
• Jasper Ridge Biological PreservecoreStrategic or Co-development PartnerField research site for plant pathogen community studies in California grasslands, located seven miles from Stanford main campus.
• Broad InstituteminorStrategic or Co-development PartnerErin Mordecai and lab members presented in the Broad Institute's Models, Inference, and Algorithms seminar on climate change impacts on dengue.
• Georgia TechminorStrategic or Co-development PartnerMallory Harris collaborated with Profs. Joshua Weitz and Clio Andris at Georgia Tech to create the COVID-19 Event Risk Assessment tool.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Center for Infectious Disease Dynamics (CIDD), Penn State: Interdisciplinary academic center at Penn State focused on disease ecology across human, animal, and plant systems, with strong mathematical modeling and field research components. One of the closest academic analogues to Mordecai Lab in scope, method, and training role.
• Barcelona Institute for Global Health (ISGlobal): Research institute with a major program on climate change, urban planning, and vector-borne diseases (notably malaria and dengue) in low- and middle-income countries. Comparable in combining climate-driven transmission modeling with field epidemiology in endemic regions, and is an active node in the same collaborator network as Mordecai Lab.
• Institute for Disease Modeling (IDM): Affiliated with the Gates Foundation, IDM develops and applies mathematical models of infectious disease transmission — including malaria and vector-borne diseases — to inform global health decision-making. Directly comparable in mathematical modeling + empirical data approach for vector-borne diseases.
• EcoHealth Alliance: Non-profit research organization focused on understanding the connections between human, animal, and environmental health, with strong emphasis on disease ecology, pandemic prediction, and field-based infectious disease research. Highly comparable to Mordecai Lab in mission, methods (modeling + empirical work), and One Health framing of vector-borne and zoonotic disease.
• Bernhard Nocht Institute for Tropical Medicine: German research institute focused on tropical medicine, including laboratory and field research on vector-borne pathogens (malaria, dengue, and other arboviruses). Comparable as a non-commercial research entity combining empirical and modeling work on the same disease systems Mordecai Lab studies.

Others

• Broad Institute: Major genomics and biomedical research institute with infectious disease programs including malaria and arbovirus research, and an active collaborator of Mordecai Lab (hosted seminar series). Broader in scope than Mordecai Lab, but overlapping in computational infectious disease research.
• Natural Capital Project (Stanford): Stanford-based research partnership applying ecosystem modeling to decisions about land use, including deforestation impacts on vector-borne disease (malaria in the Amazon). Direct funded collaborator of Mordecai Lab on the Moore Foundation deforestation-malaria project, with shared modeling and field-research methodology.

Broad incumbents

• Pasteur Institute: Long-established non-profit research foundation conducting infectious disease research across virology, parasitology, epidemiology, and public health, with significant vector-borne disease programs. A much broader incumbent, but with overlapping core activity on malaria, arboviruses, and host-parasite dynamics.
• London School of Hygiene & Tropical Medicine (LSHTM): Large, established academic institution conducting broad-based research on tropical and vector-borne diseases including malaria, dengue, and arboviruses, with significant climate-health modeling capacity. A broader incumbent operating at much larger scale but overlapping substantively on vector-borne disease and climate-driven transmission modeling.

Regional players

• Ifakara Health Institute: Tanzania-based research organization conducting health systems and biomedical research with major programs on malaria and other vector-borne diseases, including modeling and field intervention studies. Comparable on the empirical/modeling mix for vector-borne disease, though anchored in East Africa rather than North America.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mordecai Lab